Advanced search
Publication Cover
Modern Rheumatology Volume 21, 2011 - Issue 6
Journal homepage
35
Views
13
CrossRef citations to date
0
Altmetric
Case Report

A patient with rheumatoid arthritis treated with tocilizumab together with lamivudine prophylaxis after remission of infliximab-reactivated hepatitis B

Hideki TsuboiDepartment of Orthopaedic Surgery, National Hospital Organization Osaka Minami Medical Center, 2-1 Kidohigashi, Kawachinagano, Osaka 586-8521, Japan
,
Akira TsujiiDepartment of Orthopaedic Surgery, Osaka Rosai Hospital, 1179-3 Nagasone-cho, Sakai 591-8025, Japan
,
Akihide NampeiDepartment of Orthopaedic Surgery, Osaka Rosai Hospital, 1179-3 Nagasone-cho, Sakai 591-8025, Japan
,
Harumasa YoshiharaDepartment of Gastroenterology, Osaka Rosai Hospital, 1179-3 Nagasone-cho, Sakai 591-8025, Japan
,
Kiyoshi KawanoDepartment of Clinical Pathology, Osaka Rosai Hospital, 1179-3 Nagasone-cho, Sakai 591-8025, Japan
,
Eiji TakeuchiDepartment of Orthopaedic Surgery, NTT West Osaka Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka 543-8922, Japan
&
Kenrin ShiDepartment of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, JapanCorrespondence[email protected]
 show all
Pages 701-705 | Received 07 Dec 2010, Accepted 06 May 2011, Published online: 02 Jan 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Mauro Viganò, Giuseppe Serra, Giovanni Casella, Glenda Grossi & Pietro Lampertico. (2016) Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders. Expert Opinion on Biological Therapy 16:7, pages 917-926.
Read now
Christos Koutsianas, Konstantinos Thomas & Dimitrios Vassilopoulos. (2016) Prevention of HBV reactivation in patients treated with biologic agents. Expert Review of Clinical Pharmacology 9:4, pages 579-589.
Read now

Articles from other publishers (11)

Christos Koutsianas, Konstantinos Thomas & Dimitrios Vassilopoulos. (2020) Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations. Therapeutic Advances in Musculoskeletal Disease 12, pages 1759720X2091264.
Crossref
Andrew Ustianowski & Karen Devine. 2020. Infections in Systemic Autoimmune Diseases: Risk Factors and Management. Infections in Systemic Autoimmune Diseases: Risk Factors and Management 59 82 .
K.L. Winthrop, X. Mariette, J.T. Silva, E. Benamu, L.H. Calabrese, A. Dumusc, J.S. Smolen, J.M. Aguado & M. Fernández-Ruiz. (2018) ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors). Clinical Microbiology and Infection 24, pages S21-S40.
Crossref
Yi-Ming Chen, Sheng-Shun Yang & Der-Yuan Chen. (2017) Risk-stratified management strategies for HBV reactivation in RA patients receiving biological and targeted therapy: A narrative review. Journal of Microbiology, Immunology and Infection.
Crossref
Le-Feng Chen, Ying-Qian Mo, Jun Jing, Jian-Da Ma, Dong-Hui Zheng & Lie Dai. (2017) Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation. International Journal of Rheumatic Diseases 20:7, pages 859-869.
Crossref
Stefan Rose-John, Kevin Winthrop & Leonard Calabrese. (2017) The role of IL-6 in host defence against infections: immunobiology and clinical implications. Nature Reviews Rheumatology 13:7, pages 399-409.
Crossref
Christos Koutsianas, Konstantinos Thomas & Dimitrios Vassilopoulos. (2017) Hepatitis B Reactivation in Rheumatic Diseases. Rheumatic Disease Clinics of North America 43:1, pages 133-149.
Crossref
J. Steuart Richards, Sharon Dowell & Mercedes Quinones. 2017. Comorbidity in Rheumatic Diseases. Comorbidity in Rheumatic Diseases 345 380 .
Worawit Louthrenoo. (2015) Treatment considerations in patients with concomitant viral infection and autoimmune rheumatic diseases. Best Practice & Research Clinical Rheumatology 29:2, pages 319-342.
Crossref
Anna Felis-Giemza, Marzena Olesińska, Katarzyna Świerkocka, Ewa Więsik-Szewczyk & Ewa Haładyj. (2014) Treatment of rheumatic diseases and hepatitis B virus coinfection. Rheumatology International 35:3, pages 385-392.
Crossref
Dimitrios Vassilopoulos & Leonard H. Calabrese. (2012) Management of rheumatic disease with comorbid HBV or HCV infection. Nature Reviews Rheumatology 8:6, pages 348-357.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.